“Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results”. 2017. SKIN The Journal of Cutaneous Medicine 1 (3.1): s102. https://doi.org/10.25251/skin.1.supp.101.